華蟾酥毒基
分析標(biāo)準(zhǔn)品,HPLC≥98%
Cinobufagin
CAS號(hào)：470-37-1
分子式：C26H34O6
分子量：442.55
MDL：MFCD00056825
貨號(hào) | 規(guī)格/參數(shù)/品牌 | 價(jià)格 | 貨期 |
YJ-B20542-20mg | 分析標(biāo)準(zhǔn)品,HPLC≥98% | ￥500.00 | 現(xiàn)貨 |
YJ-B20542-100mg | 分析標(biāo)準(zhǔn)品,HPLC≥98% | ￥1300.00 | 現(xiàn)貨 |
A10114-20mg | 分析標(biāo)準(zhǔn)品,含量97.5%，可溯源 | ￥700.00 | 現(xiàn)貨 |
產(chǎn)品介紹
熔點(diǎn)：222-223℃
沸點(diǎn)：595.4 ℃ at 760 mmHg
外觀：白色針晶
溶解性：易溶于氯仿、甲醇等有機(jī)溶劑，不溶于水。
儲(chǔ)存條件：2-8℃,避光
注意：部分產(chǎn)品我司僅能提供部分信息，我司不保證所提供信息的權(quán)威性，僅供客戶參考交流研究之用。
參考文獻(xiàn)(11篇)
11. [IF=3.4] Pin Wang et al."Exploring the mechanism of cinobufagin on gastric cancer based on proteomics, molecular dynamics, in vitro and in vivo experiment."TOXICOLOGY AND APPLIED PHARMACOLOGY.2025 Oct;503:117490
10. [IF=4.8] Hongxuan Yang et al."Huachansu suppresses colorectal cancer via inhibiting PI3K/AKT and glycolysis signaling pathways: Systems biology and network pharmacology."JOURNAL OF ETHNOPHARMACOLOGY.2025 Feb;:119479
9. [IF=7.9] Yi-Qing Deng et al."Compound-composed Chinese medicine of Huachansu triggers apoptosis of gastric cancer cells through increase of reactive oxygen species levels and suppression of proteasome activities."PHYTOMEDICINE.2023 Oct;:155169
8. [IF=3.889] Yaoyao Bian et al."Cinobufagin induces acute promyelocytic leukaemia cell apoptosis and PML-RARA degradation in a caspase-dependent manner by inhibiting the β-catenin signalling pathway."PHARMACEUTICAL BIOLOGY
7. [IF=1.902] Ke-ke Cui et al."Quantitative analysis of multicomponents by a single marker and quality evaluation of Venenum Bufonis from different geographical origins."Biomed Chromatogr. 2019 Sep;33(9):e4555
6. [IF=4.379] Cao Yueting et al."The impact of multiple climatic and geographic factors on the chemical defences of Asian toads (Bufo gargarizans Cantor)."Sci Rep-Uk. 2019 Nov;9(1):1-11
5. [IF=4.411] Yueting Cao et al."Chemical Profile and Multicomponent Quantitative Analysis for the Quality Evaluation of Toad Venom from Different Origins."Molecules. 2019 Jan;24(19):3595
4. [IF=2.193] Zhang Mei-Tuo et al."Strategic Combination of Isocratic and Gradient Elution for Simultaneous Separation of Polar Compounds in Traditional Chinese Medicines by HPLC."J Anal Methods Chem. 2018;2018:7569283
3. 張妹砣 李玉桑 葉曉雪. 六神丸血漿藥物化學(xué)的研究[J]. 綠色科技 2017 000(012):237-240.
2. 李志東 朱士春 葛朝暉. HPLC法測(cè)定不同批次麝香保心丸中華蟾酥毒基與脂蟾毒配基的含量[J]. 海峽藥學(xué) 2017 029(012):72-74.
1. 牛天力 秦國(guó)政. 華蟾酥毒基抑制人前列腺癌PC3細(xì)胞體外增殖研究[J]. 北京中醫(yī)藥大學(xué)學(xué)報(bào) 2018 41(12):53-58.
從2011年開始我們致力于在生命科學(xué)領(lǐng)域、生物醫(yī)學(xué)實(shí)驗(yàn)技術(shù)及論文潤(rùn)色服務(wù)，協(xié)助客戶各類實(shí)驗(yàn)服務(wù)及論文潤(rùn)色十多年，是您值得信賴的科研合作伙伴!
如果您受時(shí)間、試驗(yàn)條件等限制而無(wú)法完成您的課題研究，歡迎您與我們聯(lián)系。
實(shí)驗(yàn)技術(shù)服務(wù)：
實(shí)驗(yàn)室代做實(shí)驗(yàn)項(xiàng)目
| |||
細(xì)胞熒光染料標(biāo)記檢測(cè)實(shí)驗(yàn)
| |||
| |||
染色質(zhì)免疫沉淀分析(CLIP)實(shí)驗(yàn)服務(wù)
| |||
| |||
|
